Notebook

Seven new members joined the National Science Board (NSB) last month, the first appointees to the 24-member body by President Bill Clinton. The NSB oversees the National Science Foundation, headed by Neal Lane, who is also an ex officio member of the board. Members serve six-year terms, and eight members rotate off the board every two years--thus, the incoming group leaves one vacancy overall. Four of the new members are from universities, two from industry, and one from government. Three of th

| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Seven new members joined the National Science Board (NSB) last month, the first appointees to the 24-member body by President Bill Clinton. The NSB oversees the National Science Foundation, headed by Neal Lane, who is also an ex officio member of the board. Members serve six-year terms, and eight members rotate off the board every two years--thus, the incoming group leaves one vacancy overall. Four of the new members are from universities, two from industry, and one from government. Three of the seven are women, and one received the Nobel Prize--in economics--in 1987. The seven are Sanford D. Greenberg, chairman and chief executive officer of TEI Industries Inc., Washington, D.C.; Eve L. Menger, director of technical services and administration, Corning Inc., Corning, N.Y.; Claudia I. Mitchell-Kernan, vice chancellor for academic affairs and dean of the graduate division, University of California, Los Angeles; Diana Natalicio, president of the University of Texas, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies